Somnigroup stock price target raised to $90 by KeyBanc on Mattress Firm integration

KeyBanc raised its price target on Somnigroup (SGI) to $90 from $74, maintaining an Overweight rating, citing the Mattress Firm acquisition as a multi-year value driver expected to fuel 51% revenue growth and 20% EPS growth for fiscal 2025, with potential for $300-400 million in additional EBITDA. Concurrently, Somnigroup extended its CEO's contract, repriced its $1.6 billion term loan, and slightly beat Q1 2025 adjusted EPS forecasts despite a revenue miss. However, the company is trading above its fair value according to InvestingPro, and it launched a secondary stock offering of over 15 million shares.

Analysis

KeyBanc has upgraded its price target for Somnigroup (SGI) to $90.00 from $74.00, reinforcing an Overweight rating based on the transformative potential of its Mattress Firm acquisition. The firm projects this integration will be a multi-year value driver, forecasting 51% revenue growth in fiscal 2025 and a sustained 20% annual EPS growth. A key synergy highlighted is the potential to increase Somnigroup's product share within Mattress Firm stores to 60%, which could organically add $300-400 million in EBITDA over the next decade. This bullish outlook is tempered by conflicting signals; while Somnigroup's stock has returned 46.31% over the past year and trades near its 52-week high, InvestingPro analysis suggests it is currently valued above its fair value. Recent Q1 2025 results were mixed, with an adjusted EPS of $0.49 slightly beating forecasts, but revenue of $1.6 billion falling short of the $1.63 billion expectation. Concurrently, the company has demonstrated proactive financial and strategic management by extending its CEO's contract through 2029, repricing a $1.6 billion term loan to reduce margins by 25 basis points, prepaying $100 million in debt, and launching a secondary offering of over 15 million shares.

Key Decisions for Investors

• Investors should weigh the significant long-term growth potential outlined by KeyBanc, driven by the Mattress Firm acquisition synergies, against current valuation concerns, as the stock is trading near its 52-week high and is considered overvalued by some metrics.
• Monitor the execution risk associated with the integration, specifically tracking progress towards increasing Somnigroup's sales share within Mattress Firm, as this is the primary driver for the projected $300-400 million EBITDA uplift.
• Consider the near-term impact of the 15 million share secondary offering, which will create dilution for existing shareholders, and assess the company's ability to maintain its growth trajectory despite the recent first-quarter revenue miss.